K., Yamada, K., Chiku, T., Koutmos, M
The results were reported at the American Diabetes Association 2026 Scientific Sessions in New Orleans and were published in AstraZenecas elecoglipron is the latest GLP-1 medication to be developed in pill form, rather than injectable treatments like Ozempic, Wegovy, Zepbound, and Mounjaro
Its been a little while, and Ive missed you guys so, so much
In a retrospective study completed by Nadeem et al., it was shown that GLP-1 RAs are associated with an overall fourfold increase in the retention of gastric contents in both diabetic and non-diabetic patients ( p -value 0.8 mL/kg of gastric fluid content (measured from the aspiration/suction canister)
doi: 10.2337/db10-0474 158 JelsingJVrangNHansenGRaunKTang-ChristensenMKnudsenLB
The peptide storage guide covers best practices for maintaining compound integrity